AHRSeptember 2, 2026 at 8:50 PM UTCEquity Real Estate Investment Trusts (REITs)

AHR CFO Transition: Peay Retires, Chang Joins from Public Storage

Read source article

What happened

American Healthcare REIT announced that CFO Brian Peay will retire after 10 years, with Aric Chang from Public Storage set to take over effective October 1, 2026. Peay oversaw AHR's transformation from a non-traded REIT to a NYSE-listed company and a period of aggressive acquisition-driven growth. Chang brings experience as CFO of Real Estate at Public Storage, a larger and more conservatively capitalized REIT, which could signal a shift in financial strategy. The transition comes at a critical juncture as AHR relies heavily on equity issuance and must prove disciplined capital deployment to support its premium valuation. While the appointment may bring fresh perspective, it does not alter the fundamental concern that growth is normalizing while the stock trades at a lofty 32x EV/EBITDA multiple.

Implication

With Peay's departure, AHR loses deep institutional knowledge during a period of heavy capital markets activity and integration of recent acquisitions. Chang's background at Public Storage suggests potential for more conservative balance sheet management, but continuity risk and potential strategic shifts introduce uncertainty. Investors should closely monitor the new CFO's commentary on acquisition pacing, ATM usage, and dividend policy in upcoming quarters. The core thesis of overvaluation remains unless 2026 guidance surprises materially to the upside. Until clear evidence of re-accelerating per-share growth emerges, rallies toward the $52 trim level are opportunities to reduce exposure.

Thesis delta

The CFO change does not fundamentally alter the investment thesis. While the new CFO from Public Storage may bring a more disciplined capital allocation approach, the transition introduces execution uncertainty during a critical period of external growth reliance. Overall, the thesis remains unchanged: the stock is overvalued relative to expected growth normalization, and a potential sell with trim above $52 is warranted.

Confidence

moderate